REPH Recro Pharma Inc.

+0.19  (+2%)
Previous Close 9.68
Open 9.69
Price To Book -11.48
Market Cap 218,456,540
Shares 22,133,388
Volume 127,482
Short Ratio
Av. Daily Volume 244,814

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

First CRL announced May 24, 2018. Second CRL issued March 22, 2019.
Intravenous (IV) meloxicam
Acute pain following bunionectomy surgery

Latest News

  1. Should You Worry About Recro Pharma, Inc.'s (NASDAQ:REPH) CEO Salary Level?
  2. What Did Recro Pharma, Inc.'s (NASDAQ:REPH) CEO Take Home Last Year?
  3. Edited Transcript of REPH earnings conference call or presentation 10-May-19 12:00pm GMT
  4. 7 Top-Rated Biotech Stocks to Invest In Today
  5. Update: Recro Pharma (NASDAQ:REPH) Stock Gained 68% In The Last Year
  6. 7 A-Rated Stocks to Buy Under $10
  7. Recro Pharma to Present at Upcoming Investor Conferences
  8. Catalyst Pharma (CPRX) Rides on Successful Launch of Firdapse
  9. Catalent Acquires Gene Therapy Leader Paragon Bioservices
  10. New Strong Buy Stocks for May 20th
  11. Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start
  12. Recro Pharma (REPH) Reports Q1 Loss, Tops Revenue Estimates
  13. Recro Pharma: 1Q Earnings Snapshot
  14. Recro Pharma Reports First Quarter 2019 Financial Results
  15. Recro Pharma, Inc. (REPH): Here are Midwood Capital Management’s Thoughts On The Pharmaceutical Company
  16. Jazz Pharma (JAZZ) Q1 Earnings and Sales Beat Estimates
  17. Small Drug Stocks Outlook: Near-Term Prospects Encouraging
  18. Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019
  19. Recro Pharma (REPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
  20. Here is What Artko Capital Thinks About Recro Pharma, Inc. (REPH)